Vallon Pharmaceuticals
(NASDAQ) VLON
Vallon Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$11.96
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
VLON News
VLON: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vallon Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
W. Marc Hertz, PhD
Website
www.gribio.comHeadquarters
Philadelphia, PA 19103, US
VLON Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
N/A
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Payout Ratio
N/A
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Vallon Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+1.0%
Gross Margin
N/A
N/A
Market Cap
N/A
N/A
Market Cap/Employee
$0.86
N/A
Employees
4
N/A
Net Income
$2.66
+1.4%
EBITDA
$2.66
+1.4%
Quarterly Fundamentals
Net Cash
$8.23
+1.6%
Accounts Receivable
N/A
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.01
+0.2%
Short Term Debt
$0.06
+1.2%
Return on Assets
-166.00%
+0.9%
Return on Invested Capital
-962.44%
+1.0%
Free Cash Flow
$2.97
+1.5%
Operating Cash Flow
$2.97
+1.5%